Why is Medinova Diagno. falling/rising?

As of 25-Aug, Medinova Diagnostic Services Ltd is experiencing a slight increase in its stock price, currently at 41.10, reflecting a change of 0.1 or 0.24% upward. The stock has shown a trend reversal by gaining after three consecutive days of decline, although it has underperformed the benchmark Sensex over the past week and month, with returns of -1.20% and -2.49% respectively. Despite this, the stock has outperformed the sector by 0.88% today and has demonstrated strong long-term performance, with a year-to-date return of 10.34% compared to the Sensex's 4.48%. However, the company faces challenges, including a negative book value and high debt levels, which contribute to its weak long-term fundamental strength. In the broader market context, while Medinova's short-term performance has lagged behind the Sensex, its long-term returns have been favorable, outperforming the benchmark over the past three years, one year, and three months. The stock's liquidity appears adequate for trading, but a significant drop in delivery volume indicates falling investor participation, which could be a concern for future price movements. The company's flat results in June and poor growth metrics, such as a low return on capital employed and stagnant operating profit, suggest underlying weaknesses that may impact investor sentiment despite the recent price increase.